echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The first in the country!

    The first in the country!

    • Last Update: 2022-02-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Cube Info

    On January 10, the official website of CDE showed that the clinical application of Sunshine Guojian's monoclonal antibody SSGJ-617 targeting PSGL-1, a subsidiary of 3SBio, was accepted by the State Food and Drug Administration


    SSGJ-617 (VTX-0811) was developed by Verseau.


    PSGL-1 is the first target in Verseau's pipeline of macrophage checkpoint modulators to enter development


    On November 18, 2019, 3SBio and Verseau reached a licensing agreement to select VTX-0811 as the first licensed product


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.